-
1دورية أكاديمية
المؤلفون: Hutson, Thomas E.1 (AUTHOR) thomas.hutson@usoncology.com, Michaelson, M. Dror2 (AUTHOR), Kuzel, Timothy M.3 (AUTHOR), Agarwal, Neeraj4 (AUTHOR), Molina, Ana M.5 (AUTHOR), Hsieh, James J.6 (AUTHOR), Vaishampayan, Ulka N.7 (AUTHOR), Xie, Ran8 (AUTHOR), Bapat, Urmi8 (AUTHOR), Ye, Weifei9 (AUTHOR), Jain, Rohit K.10 (AUTHOR), Fishman, Mayer N.11 (AUTHOR)
المصدر: European Urology. Aug2021, Vol. 80 Issue 2, p162-170. 9p.
مصطلحات موضوعية: *RENAL cell carcinoma, *PROTEIN-tyrosine kinase inhibitors, *EVEROLIMUS, *OVERALL survival, *PROGRESSION-free survival, *MTOR inhibitors
-
2دورية أكاديمية
المؤلفون: Motzer, Robert J.1 (AUTHOR) motzerr@mkscc.org, Choueiri, Toni K.2 (AUTHOR), Hutson, Thomas3 (AUTHOR), Young Rha, Sun4 (AUTHOR), Puente, Javier5 (AUTHOR), Lalani, Aly-Khan A.6 (AUTHOR), Winquist, Eric7 (AUTHOR), Eto, Masatoshi8 (AUTHOR), Basappa, Naveen S.9 (AUTHOR), Tannir, Nizar M.10 (AUTHOR), Vaishampayan, Ulka11 (AUTHOR), Bjarnason, Georg A.12 (AUTHOR), Oudard, Stéphane13 (AUTHOR), Grünwald, Viktor14 (AUTHOR), Burgents, Joseph15 (AUTHOR), Xie, Ran16 (AUTHOR), McKenzie, Jodi16 (AUTHOR), Powles, Thomas17 (AUTHOR)
المصدر: European Urology. Jul2024, Vol. 86 Issue 1, p4-9. 6p.
مصطلحات موضوعية: *SURVIVAL analysis (Biometry), *RENAL cell carcinoma, *CANCER patients, *PEMBROLIZUMAB, *CLINICAL trials, *OVERALL survival
-
3دورية أكاديمية
المؤلفون: Powles, Thomas1 (AUTHOR) Thomas.Powles@bartshealth.nhs.uk, Atkins, Michael B.2 (AUTHOR), Escudier, Bernard3 (AUTHOR), Motzer, Robert J.4 (AUTHOR), Rini, Brian I.5 (AUTHOR), Fong, Lawrence6 (AUTHOR), Joseph, Richard W.7 (AUTHOR), Pal, Sumanta K.8 (AUTHOR), Sznol, Mario9 (AUTHOR), Hainsworth, John10 (AUTHOR), Stadler, Walter M.11 (AUTHOR), Hutson, Thomas E.12 (AUTHOR), Ravaud, Alain13 (AUTHOR), Bracarda, Sergio14 (AUTHOR), Suarez, Cristina15 (AUTHOR), Choueiri, Toni K.16 (AUTHOR), Reeves, James17 (AUTHOR), Cohn, Allen18 (AUTHOR), Ding, Beiying19 (AUTHOR), Leng, Ning19 (AUTHOR)
المصدر: European Urology. May2021, Vol. 79 Issue 5, p665-673. 9p.
مصطلحات موضوعية: *RENAL cell carcinoma, *DRUG efficacy, *BEVACIZUMAB, *VASCULAR endothelial growth factors, *DISEASE progression, *ATEZOLIZUMAB
-
4دورية أكاديمية
المؤلفون: Basch, Ethan M.1 (AUTHOR) ebasch@med.unc.edu, Scholz, Mark2 (AUTHOR), de Bono, Johann S.3 (AUTHOR), Vogelzang, Nicholas4 (AUTHOR), de Souza, Paul5 (AUTHOR), Marx, Gavin6 (AUTHOR), Vaishampayan, Ulka7 (AUTHOR), George, Saby8 (AUTHOR), Schwarz, James K.9 (AUTHOR), Antonarakis, Emmanuel S.10 (AUTHOR), O'Sullivan, Joseph M.11 (AUTHOR), Kalebasty, Arash Rezazadeh12 (AUTHOR), Chi, Kim N.13 (AUTHOR), Dreicer, Robert14 (AUTHOR), Hutson, Thomas E.15 (AUTHOR), Dueck, Amylou C.16 (AUTHOR), Bennett, Antonia V.17 (AUTHOR), Dayan, Erica18 (AUTHOR), Mangeshkar, Milan19 (AUTHOR), Holland, Jaymes1,19 (AUTHOR)
المصدر: European Urology. Jun2019, Vol. 75 Issue 6, p929-937. 9p.
مصطلحات موضوعية: *CASTRATION-resistant prostate cancer, *CANCER pain, *BRIEF Pain Inventory, *BONE metastasis, *DRUG abuse
-
5دورية أكاديمية
المؤلفون: Pal, Sumanta K.1 (AUTHOR), Escudier, Bernard J.2 (AUTHOR), Atkins, Michael B.3 (AUTHOR), Hutson, Thomas E.4 (AUTHOR), Porta, Camillo5 (AUTHOR), Verzoni, Elena6 (AUTHOR), Needle, Michael N.7 (AUTHOR), Powers, Daniel7 (AUTHOR), McDermott, David F.8 (AUTHOR), Rini, Brian I.1,9 (AUTHOR) brian.rini@vumc.org
المصدر: European Urology. Dec2020, Vol. 78 Issue 6, p783-785. 3p.
مصطلحات موضوعية: *RENAL cell carcinoma, *SORAFENIB, *VASCULAR endothelial growth factor receptors, *RENAL cancer, *PROGRESSION-free survival
-
6دورية أكاديمية
المؤلفون: Vogelzang, Nicholas J.1,2 Nicholas.Vogelzang@usoncology.com, Fizazi, Karim3, Burke, John M.1,4, De Wit, Ronald5, Bellmunt, Joaquim6,7, Hutson, Thomas E.8, Crane, Edward9, Berry, William R.10, Doner, Kevin11, Hainsworth, John D.12, Wiechno, Pawel J.13, Liu, Kejian14, Waldman, Michelle F.14, Gandhi, Anita14, Barton, Debora14, Jungnelius, Ulf14, Fandi, Abderrahim14, Sternberg, Cora N.15, Petrylak, Daniel P.16
المصدر: European Urology. Feb2017, Vol. 71 Issue 2, p168-171. 4p.
مصطلحات موضوعية: *DOCETAXEL, *PREDNISONE, *PROSTATE cancer treatment, *CANCER chemotherapy, *CLINICAL trials
-
7دورية أكاديمية
المؤلفون: Porta, Camillo1 c.porta@smatteo.pv.it, Calvo, Emiliano2, Climent, Miguel A.3, Vaishampayan, Ulka4, Osanto, Susanne5, Ravaud, Alain6, Bracarda, Sergio7, Hutson, Thomas E.8, Escudier, Bernard9, Grünwald, Viktor10, Kim, Dennis11, Panneerselvam, Ashok12, Anak, Oezlem13, Motzer, Robert J.14
المصدر: European Urology. Apr2012, Vol. 61 Issue 4, p826-833. 8p.
مصطلحات موضوعية: *CANCER treatment, *RENAL cell carcinoma, *DRUG efficacy, *IMMUNOSUPPRESSIVE agents, *RANDOMIZED controlled trials, *COMORBIDITY, *HEALTH outcome assessment, *OLDER patients
-
8دورية أكاديمية
المؤلفون: Sonpavde, Guru1,2 guru.sonpavde@usoncology.com, Choueiri, Toni K.3, Escudier, Bernard4, Ficarra, Vincenzo5, Hutson, Thomas E.6, Mulders, Peter F.7, Patard, Jean-Jacques8, Rini, Brian I.9, Staehler, Michael10, Sternberg, Cora N.11, Stief, Christian G.12
المصدر: European Urology. Feb2012, Vol. 61 Issue 2, p307-316. 10p.
مصطلحات موضوعية: *RENAL cell carcinoma, *CANCER treatment, *ANTINEOPLASTIC agents, *BIOMARKERS, *TARGETED drug delivery, *VASCULAR endothelial growth factors, *RAPAMYCIN, *PROTEIN-tyrosine kinase inhibitors, *CYTOKINES, *CLINICAL trials